Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C

International Journal of Psychiatry in Medicine

Volumn 36, Issue 3, 2006, Pages 283-297

  Özkan, Mine ^a   Çorapçioglu, Aytül ^b   Balcioglu, Ibrahim ^c   Ertekin, Erhan ^a   Khan, Sila ^b   Özdemir, Samuray ^c   Karayün, Deniz ^a   Ünsalver, Bariş Önen ^c   Kocaman, Nazmiye ^a   Kaymakglu, Sabahattin ^a   Köroglu, Gültürk ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c Cerrahpa a Faculty of Medicine

Author keywords

Chronic illness; Depression; Health related quality of life; Hepatitis B; Hepatitis C; Psychiatric morbidity

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORBIDITY; PREVALENCE; PSYCHIATRY; QUALITY OF LIFE; SHORT FORM 36; STATISTICAL SIGNIFICANCE; COMORBIDITY; PSYCHOLOGICAL ASPECT; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ADULT; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C; HOSPITALS, UNIVERSITY; HUMANS; MALE; QUALITY OF LIFE; TURKEY;

EID: 33947507539     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/D37Y-X0JY-39MJ-PVXQ     Document Type: Article

References (67)

1. Hoofnagle JH. Hepatitis C: The clinical spectrum of disease. Hepatology 1997;26(Suppl):15-20.
2. Shaw-Stiffel TA. Chronic hepatitis. In Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 5 ed. Philadelphia: Churchill Livingstone, 2000:1297-1331.
3. Williams I. Epidemiology of hepatitis C in the United States. American Journal of Medicine 1999;107 (suppl):2-9.
4. Tasyaran MA. Epidemiology of hepatitis B virus infection. In K. Kilicturgay K, Badur S, editors. Viral Hepatit 2001. Istanbul: Deniz Press, 2004:121-129 [Turkish].
5. Gürbüz AK, Doǧalp K, Gülşen M ve ark. Familial Transmission in Hepatitis C infection. Gastroenteroloji 1993;4:405-408 [Turkish].
6. Lauer GM, Walker BD. Hepatitis C virus infection. New England Journal of Medicine 2001;345:41-52.
7. El-Sarag HB. Epidemiology of hepatocellular carcinoma. Clinical Liver Disease 2001;5:87-107, vi.
8. Kraus MR, Schafer A, Csef H, Scherulen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000;41:377-384.
9. Caravati CM. Posthepatitis syndrome. Southern Medical Journal 1944;37:251-257.
10. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne Non-A, Non-B viral hepatitis genome. Science 1989;244:359-361.
11. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human Non-A, Non-B hepatitis. Science 1989;244:362-364.
12. Kunkel EJS, Kim JS, Hann HW, Oyesanmi O, Menefee LA, Field HL, Lartey PL, Myers RE. Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics 2000;41:472-480.
13. Yovtcheva SP, Rifai MA, Moles JK, Van Der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001;42:411-415.
14. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. American Journal of Psychiarty 2000;157:867-876.
15. Singh N, Gayowski T, Wagener MM, et al. Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clinical Transplantation 1997;11:406-411.
16. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. New England Journal of Medicine 1989;321:1501-1510.
17. Hunt CM, Dominitz JA, Bute BP, et al. Effect of interferon- treatment on chronic hepatitis C on health-related quality of life. Dig Dis Sci 1997;42:2482-2486.
18. Pariante C, Orru M, Baita A, et al. Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999;354:131-132.
19. Atesci FC, Cetin BC, Oguzhanoglu NK, Karadag F, Turgut H. Psychiatric disorders and functioning hepatitis B virus carriers. Psychosomatics 2005;46:142-147.
20. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in HRQOL in the absence of cirrhosis. Hepatology 1998;27:209-212.
21. Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C. Interferon alfa, and depression. Hepatology 2000;31:1207-1211.
22. Bell J, Batey RG, Farrell GC, Crewe EB, Cinningham AL, Byth K. Hepatitis C virus in intravenous drug users. Medical Journal of Australia 1990;153:274-276.
23. Lee DH, Jamal H, Regenstein FG, Perrillo RP. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997;42:186-191.
24. El-Sarag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002;123:476-482.
25. Lehman CL, Cheung RC. Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. American Journal of Gastroenterology 2002;97:2640-2646.
26. Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. General Hospital Psychiatry 2005;27:431-438.
27. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. American Journal of Psychiatry 1988;145:976-981.
28. Minagawa H, Uchitomi Y, Yamawaki S. Psychiatric Morbidity in terminally ill cancer patients. Cancer 1996;78:1131-1137.
29. Ozmen E, Aydemir O, Icelli I: The distribution of psychiatric diagnoses in patients with physical diseases. Ege Psikiyatri Sürekli Yay1nlar1 Konsültasyon Liyezon Psikiyatrisi II, 1997;285-298 [Turkish].
30. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatique, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research 2000;49(5):311-317.
31. Carithers RL, Sugano D, Bayliss M. Health assessment for chronic HCV. Dig Dis Sci 1996;41(Suppl):75-80.
32. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer Jr HC, Perillo RP, et al. Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clinical Therapy 1994;16:334-343.
33. Bonkowsky HL, Woolley JM. Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999;29:264-270.
34. Ware JE, Snow KK, Kosinkio M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
35. McHutchison JG, Ware JE, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP. The effects of interferon alfa 2b in combination with ribavirin on health related quality of life and work productivity. Journal of Hepatology 2001;34:140-147.
36. Dore GJ, Freeman AJ, Law M, et al. Is severe liver disease a common outcome for people with chronic hepatitis C? Journal of Gastroenterology and Hepatology 2002;17:423-430.
37. The Consensus IFN Study Group, Bonkovsky HL, Wooley JM. Reduction of HRQOL in chronic hepatitis C and improvement with IFN therapy. Hepatology 1999;29:264-270.
38. Fontana RJ, Moyer CA, Sonnad S, Lok ASF, Sneed-Pee N, Walsh J, et al. Co-morbidities and quality of life in patients with interferon refractory chronic hepatitis C. American Journal of Gastroenterology 2001;96:170-178.
39. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CD). Washington, DC: American Psychiatric Press, 1997.
40. Ozkurkcugil A, Aydemir O, Yildiz M. Adaptation to Turkish and reliability study of Structured Clinical Interview for Axial I disorders. Ilaç ve Tedavi Dergisi 1999;12:233-236 [Turkish].
41. Beck AT: An inventory measuring depression. Archives in General Psychiatry 1961;4:561-571.
42. Hisli N. Reliability and validity of Beck depression inventory on college students. Turkish Psychological Review 1989;7:3-13 [Turkish].
43. Koçyiǧit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A. Reliability and Validity of Turkish version of Short Form-36 (SF-36). İlaç ve Tedavi Dergisi 1999;12:102-6 [Turkish].
44. Kuey L, Ustun TB, Gulec C. A study that examine the epidemiology of psychiatric disorders in Turkey. Toplum ve Hekim 1987;44:16-30 [Turkish].
45. Ögel K. Social psychiatry. In Güleç C, Koroglu E, editors, Basic Psychiatry. Ankara: Physicians Publication, 1998:1319-1328
46. Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok ASF. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology 2002;36:401-407.
47. Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardina J. Quality of life and cognitive function in hepatitis C at different stages of liver disease. Journal of Hepatology 2003;39: 231-238.
48. Gallegos-Orozco JF, Fuentes AP, Argueta JG, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, Cruz-Castellanos S, Gutiérrez- Reyes G, Olivera-Martínez MA, Gutiérrez-Ruiz MC, Kershenobich D. Health-Related Quality of Life and Depression in Patients with Chronic Hepatitis C. Archives of Medical Research 2003;34:124-129.
49. McDonald EM, Mann AH, Thomas HC. Interferons as mediators of psychiatric morbidity: An investigation in a trial of recombinant alpha interferon in hepatitis B carriers. Lancet 1987;2(21):1175-1178.
50. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, lotze MT, Chang AE, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine 1987;107:293-300.
51. Lok ASF, van Leeuwen DJ, Thomas HC, Sherlock S: Psychosocial impact of chronic infection with hepatitis B virus on British patients. Genitourin Med 1985;61:279-282.
52. Ware JE, Kosinski M, Keller S. SF-36 physical and mental health summary scores: A user's manual. Boston: The Health Institute, New England Medical Center, 1994.
53. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30:473-483.
54. Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. American Journal of Psychiatry 2000;157:248-254.
55. Jacobson AM, deGroot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with Type I and Type II diabetes mellitus. Quality of Life Research: International Journal of Quality of Life Aspects, Treatment, Care and Rehabilitation 1997;6:11-20.
56. Schipper H, Clinch JJ, Olweny CLM. Quality of life studies: Definitions and conceptual Issues. In Spilker B, editor, Quality of Life and Pharmacoeconomics in Clinical Trials, 2 ed. Philadelphia: Lippincott-Raven Publishers, 1996:11-23.
57. Miller ER, Hiller JE, Shaw DR. Quality of life in HCV-infection: Lack of association with ALT levels. Australia/New Zealand Journal of Public Health 2001;25:355-361.
58. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok ASF. Co-morbid illness is an important determinant of health related quality of life in patients with chronic hepatitis C. American Journal of Gastroenterology 2001;96:2727-2744.
59. Villano SA, Vlahove D, Nelson KE, et al. Persistence of viremia and the importance of long term follow-up after acute hepatitis C infection. Hepatology 1999;29:908-914.
60. Hoofnagle JH. Hepatitis C. The clinical spectrum of disease. Hepatology 1997;26(suppl):15-20.
61. Ho SB, Nguyen H, Tetrick LL, Opitz GA, Basara ML, Diepernik E. Influence of psychiatric diagnosis on interferon treatment for chronic hepatitis C in a veteran population. American Journal of Gastroenterology 2001;96:157-164.
62. Katon WK. The impact of major depression on chronic medical illness. General Hospital Psychiatry 1996;18:215-219.
63. Walker EA, Gelfand MD, Gelfand AN, Creed, Katon WJ. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. General Hospital Psychiatry 1996;18:220-229.
64. Lustman PJ, Clouse RE, Carney, RM . Depression and the reporting of diabetes symptoms. International Journal of Psychiatry in Medicine 1998;18:295-303.
65. Fann JR, Katon WJ, Uomoto JM, Esselman PC. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. American Journal of Psychiatry 1995;152:1493-1499.
66. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, et al. The functioning and well-being of depressed patients: results from the medical outcomes study. Journal of the American Medical Association 1989;262:914-919.
67. Sullivan MD, La Croix AZ, Baum C, Grothaus LC, Katon WK. Functional status in coronary artery disease: a one year prospective study of the role of anxiety and depression. American Journal of Medicine 1997;103:348-356.